deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT00031590

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Study Of Reduced Dose Craniospinal Radiotherapy (1800 cGy) And Chemotherapy In Children With Newly-Diagnosed Standard-Risk Posterior Fossa Primitive Neuro-ectodermal Tumor (PNET/Medulloblastoma)

Sponsor: Children's Hospital of Philadelphia

Conditions Brain Tumors Central Nervous System Tumors Medulloblastoma
Interventions Cisplatin Craniospinal Radiation Cyclophosphamide Etoposide Lomustine Vincristine
Updated 7 times since 2017 Last updated: Apr 3, 2019 Started: Apr 30, 2001 Primary completion: May 31, 2011 Completion: May 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was terminated prematurely due to slow accrual.

Other terminated trials from Children's Hospital of Philadelphia

See all terminations from Children's Hospital of Philadelphia

Other Brain Tumors trials with similar outcome

Browse all Brain Tumors trials

This PHASE2 trial investigates Brain Tumors and Central Nervous System Tumors and is currently terminated or withdrawn. Children's Hospital of Philadelphia leads this study, which shows 7 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~May 2019 · 11 months · monthly snapshotTerminated~May 2019 – ~Jan 2021 · 20 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 21 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. May 2019 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jun 2018 — May 2019 [monthly]

    Terminated PHASE2

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Hospital of Philadelphia
  • Emory University
  • Stanford University
Data source: Children's Hospital of Philadelphia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations